Market research
OSP.AU Osprey Medical, Inc
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 0.26
- Dividend yield
- 0.0%
- Beta
- 1.37
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- ISIN
- AU000000OSP4
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 0.26
- Dividend yield
- 0.0%
- Beta
- 1.37
About
About Osprey Medical, Inc
Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the OSP.AU discussion.
5 years, 6 months ago
Osprey Medical, Inc is currently in a long term downtrend where the price is trading 24.2% below its 200 day moving average.
From a valuation standpoint, the stock is 92.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.7.
Osprey Medical, Inc's total revenue sank by 53.1% to $865K since the same quarter in the previous year.
Its net income has increased by 33.0% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 37.0% to $-3M since the same quarter in the previous year.
Based on the above factors, Osprey Medical, Inc gets an overall score of 3/5.